ADMA icon

ADMA Biologics
ADMA

Overview Fund Activity

19 hedge funds and large institutions have $69.7M invested in ADMA Biologics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 10 closing their positions.

Holders
19
Holders Change
-8
Holders Change %
-29.63%
% of All Funds
0.51%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
2
Increased
7
Reduced
4
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
1
Perceptive Advisors
New York
$5.33M
2
IHM
2
Iguana Healthcare Management
New York
$2.17M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$167K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$990K
5
BFA
5
BlackRock Fund Advisors
California
$131K

Top Sellers

1
JGC
1
J. Goldman & Co
New York
$0
2
SM
2
Sabby Management
Florida
$0
3
UOC
3
UBS O'Connor
Illinois
$0
4
TI
4
Telemetry Investments
New York
$72K
5
PVI
5
Pura Vida Investments
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
– – -3,000 Closed
Walleye Trading
27
Walleye Trading
New York
– – -1,300 Closed
UBS Group
28
UBS Group
Switzerland
– – -160 Closed
Bank of America
29
Bank of America
North Carolina
$0 49 +19 +63%
1
2